nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—AKR1C3—stomach cancer	0.509	1	CbGaD
Medroxyprogesterone Acetate—AKR1C3—Doxorubicin—stomach cancer	0.14	0.652	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Capecitabine—stomach cancer	0.0229	0.107	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Fluorouracil—stomach cancer	0.0195	0.0906	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Fluorouracil—stomach cancer	0.0136	0.0632	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Irinotecan—stomach cancer	0.00823	0.0383	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Docetaxel—stomach cancer	0.00603	0.0281	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Doxorubicin—stomach cancer	0.0045	0.0209	CbGbCtD
Medroxyprogesterone Acetate—HSD3B2—digestive system—stomach cancer	0.00236	0.0628	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—endocrine gland—stomach cancer	0.00195	0.0519	CbGeAlD
Medroxyprogesterone Acetate—PGR—blood vessel—stomach cancer	0.00182	0.0485	CbGeAlD
Medroxyprogesterone Acetate—ESR1—blood vessel—stomach cancer	0.00142	0.0379	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—lymph node—stomach cancer	0.00135	0.0359	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—smooth muscle tissue—stomach cancer	0.00126	0.0336	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—pancreas—stomach cancer	0.00117	0.031	CbGeAlD
Medroxyprogesterone Acetate—SHBG—hematopoietic system—stomach cancer	0.00108	0.0287	CbGeAlD
Medroxyprogesterone Acetate—PGR—hematopoietic system—stomach cancer	0.000969	0.0258	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—bone marrow—stomach cancer	0.000918	0.0244	CbGeAlD
Medroxyprogesterone Acetate—PGR—epithelium—stomach cancer	0.000886	0.0236	CbGeAlD
Medroxyprogesterone Acetate—PGR—smooth muscle tissue—stomach cancer	0.000854	0.0227	CbGeAlD
Medroxyprogesterone Acetate—AR—hematopoietic system—stomach cancer	0.000772	0.0206	CbGeAlD
Medroxyprogesterone Acetate—ESR1—hematopoietic system—stomach cancer	0.000758	0.0202	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—liver—stomach cancer	0.000742	0.0197	CbGeAlD
Medroxyprogesterone Acetate—AR—epithelium—stomach cancer	0.000706	0.0188	CbGeAlD
Medroxyprogesterone Acetate—ESR1—epithelium—stomach cancer	0.000693	0.0185	CbGeAlD
Medroxyprogesterone Acetate—SHBG—bone marrow—stomach cancer	0.00069	0.0184	CbGeAlD
Medroxyprogesterone Acetate—PGR—lymphoid tissue—stomach cancer	0.000682	0.0182	CbGeAlD
Medroxyprogesterone Acetate—AR—smooth muscle tissue—stomach cancer	0.00068	0.0181	CbGeAlD
Medroxyprogesterone Acetate—ESR1—smooth muscle tissue—stomach cancer	0.000668	0.0178	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—hematopoietic system—stomach cancer	0.000625	0.0166	CbGeAlD
Medroxyprogesterone Acetate—SHBG—endocrine gland—stomach cancer	0.000618	0.0165	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—lymph node—stomach cancer	0.000569	0.0151	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—hematopoietic system—stomach cancer	0.000559	0.0149	CbGeAlD
Medroxyprogesterone Acetate—SHBG—liver—stomach cancer	0.000558	0.0148	CbGeAlD
Medroxyprogesterone Acetate—PGR—endocrine gland—stomach cancer	0.000557	0.0148	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—hematopoietic system—stomach cancer	0.000555	0.0148	CbGeAlD
Medroxyprogesterone Acetate—AR—lymphoid tissue—stomach cancer	0.000544	0.0145	CbGeAlD
Medroxyprogesterone Acetate—AR—digestive system—stomach cancer	0.000537	0.0143	CbGeAlD
Medroxyprogesterone Acetate—ESR1—lymphoid tissue—stomach cancer	0.000534	0.0142	CbGeAlD
Medroxyprogesterone Acetate—ESR1—digestive system—stomach cancer	0.000527	0.014	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—epithelium—stomach cancer	0.000511	0.0136	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—smooth muscle tissue—stomach cancer	0.000493	0.0131	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—pancreas—stomach cancer	0.000455	0.0121	CbGeAlD
Medroxyprogesterone Acetate—AR—endocrine gland—stomach cancer	0.000444	0.0118	CbGeAlD
Medroxyprogesterone Acetate—ESR1—endocrine gland—stomach cancer	0.000436	0.0116	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—hematopoietic system—stomach cancer	0.000423	0.0113	CbGeAlD
Medroxyprogesterone Acetate—AR—liver—stomach cancer	0.0004	0.0107	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—lymphoid tissue—stomach cancer	0.000394	0.0105	CbGeAlD
Medroxyprogesterone Acetate—ESR1—liver—stomach cancer	0.000393	0.0105	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—digestive system—stomach cancer	0.000389	0.0104	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—digestive system—stomach cancer	0.000386	0.0103	CbGeAlD
Medroxyprogesterone Acetate—PGR—lymph node—stomach cancer	0.000385	0.0103	CbGeAlD
Medroxyprogesterone Acetate—Hydrocortisone—ANXA1—stomach cancer	0.000362	0.56	CrCbGaD
Medroxyprogesterone Acetate—CYP2C8—endocrine gland—stomach cancer	0.000359	0.00956	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—bone marrow—stomach cancer	0.000359	0.00955	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—liver—stomach cancer	0.000324	0.00862	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—endocrine gland—stomach cancer	0.000321	0.00856	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—endocrine gland—stomach cancer	0.000319	0.00849	CbGeAlD
Medroxyprogesterone Acetate—AR—lymph node—stomach cancer	0.000307	0.00817	CbGeAlD
Medroxyprogesterone Acetate—ESR1—lymph node—stomach cancer	0.000301	0.00802	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—digestive system—stomach cancer	0.000294	0.00783	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—liver—stomach cancer	0.00029	0.00772	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—liver—stomach cancer	0.000287	0.00765	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—endocrine gland—stomach cancer	0.000243	0.00647	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—lymph node—stomach cancer	0.000222	0.00592	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—liver—stomach cancer	0.000219	0.00584	CbGeAlD
Medroxyprogesterone Acetate—Drospirenone—PTGS2—stomach cancer	0.000103	0.159	CrCbGaD
Medroxyprogesterone Acetate—Progesterone—CYP2A6—stomach cancer	9.06e-05	0.14	CrCbGaD
Medroxyprogesterone Acetate—Methyltestosterone—ALB—stomach cancer	5.76e-05	0.0891	CrCbGaD
Medroxyprogesterone Acetate—Bradycardia—Doxorubicin—stomach cancer	5.75e-05	0.000374	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Docetaxel—stomach cancer	5.73e-05	0.000372	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Docetaxel—stomach cancer	5.71e-05	0.000371	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Methotrexate—stomach cancer	5.71e-05	0.000371	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Epirubicin—stomach cancer	5.7e-05	0.000371	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Epirubicin—stomach cancer	5.69e-05	0.00037	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Methotrexate—stomach cancer	5.68e-05	0.000369	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Methotrexate—stomach cancer	5.68e-05	0.000369	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Doxorubicin—stomach cancer	5.67e-05	0.000369	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Capecitabine—stomach cancer	5.67e-05	0.000368	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Epirubicin—stomach cancer	5.66e-05	0.000368	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Fluorouracil—stomach cancer	5.66e-05	0.000368	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Docetaxel—stomach cancer	5.66e-05	0.000368	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Doxorubicin—stomach cancer	5.64e-05	0.000367	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Doxorubicin—stomach cancer	5.64e-05	0.000367	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Capecitabine—stomach cancer	5.63e-05	0.000366	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Fluorouracil—stomach cancer	5.61e-05	0.000365	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Fluorouracil—stomach cancer	5.61e-05	0.000365	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Doxorubicin—stomach cancer	5.6e-05	0.000364	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Capecitabine—stomach cancer	5.59e-05	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Docetaxel—stomach cancer	5.59e-05	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Fluorouracil—stomach cancer	5.58e-05	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Doxorubicin—stomach cancer	5.57e-05	0.000362	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Doxorubicin—stomach cancer	5.56e-05	0.000361	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Methotrexate—stomach cancer	5.56e-05	0.000361	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Docetaxel—stomach cancer	5.55e-05	0.000361	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Doxorubicin—stomach cancer	5.55e-05	0.000361	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Capecitabine—stomach cancer	5.55e-05	0.000361	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Docetaxel—stomach cancer	5.54e-05	0.00036	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Epirubicin—stomach cancer	5.54e-05	0.00036	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Doxorubicin—stomach cancer	5.53e-05	0.00036	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Irinotecan—stomach cancer	5.52e-05	0.000359	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Epirubicin—stomach cancer	5.51e-05	0.000358	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Epirubicin—stomach cancer	5.5e-05	0.000357	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Docetaxel—stomach cancer	5.5e-05	0.000357	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Methotrexate—stomach cancer	5.49e-05	0.000357	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Capecitabine—stomach cancer	5.48e-05	0.000356	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Epirubicin—stomach cancer	5.47e-05	0.000356	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Doxorubicin—stomach cancer	5.44e-05	0.000354	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Capecitabine—stomach cancer	5.41e-05	0.000352	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Epirubicin—stomach cancer	5.39e-05	0.00035	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Capecitabine—stomach cancer	5.37e-05	0.000349	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Capecitabine—stomach cancer	5.36e-05	0.000349	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Epirubicin—stomach cancer	5.34e-05	0.000347	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Doxorubicin—stomach cancer	5.34e-05	0.000347	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Capecitabine—stomach cancer	5.32e-05	0.000346	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Epirubicin—stomach cancer	5.31e-05	0.000345	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Epirubicin—stomach cancer	5.31e-05	0.000345	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Docetaxel—stomach cancer	5.3e-05	0.000344	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Fluorouracil—stomach cancer	5.29e-05	0.000344	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Doxorubicin—stomach cancer	5.28e-05	0.000343	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Methotrexate—stomach cancer	5.27e-05	0.000342	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Doxorubicin—stomach cancer	5.26e-05	0.000342	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Docetaxel—stomach cancer	5.25e-05	0.000342	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Methotrexate—stomach cancer	5.25e-05	0.000341	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Doxorubicin—stomach cancer	5.24e-05	0.000341	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Epirubicin—stomach cancer	5.23e-05	0.00034	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Epirubicin—stomach cancer	5.21e-05	0.000339	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Epirubicin—stomach cancer	5.2e-05	0.000338	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Epirubicin—stomach cancer	5.16e-05	0.000335	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Epirubicin—stomach cancer	5.14e-05	0.000334	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Capecitabine—stomach cancer	5.13e-05	0.000333	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Doxorubicin—stomach cancer	5.12e-05	0.000333	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Methotrexate—stomach cancer	5.12e-05	0.000333	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Epirubicin—stomach cancer	5.11e-05	0.000332	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Doxorubicin—stomach cancer	5.1e-05	0.000331	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Methotrexate—stomach cancer	5.1e-05	0.000331	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Capecitabine—stomach cancer	5.09e-05	0.000331	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Doxorubicin—stomach cancer	5.09e-05	0.000331	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Docetaxel—stomach cancer	5.08e-05	0.00033	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Docetaxel—stomach cancer	5.08e-05	0.00033	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Doxorubicin—stomach cancer	5.07e-05	0.000329	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Doxorubicin—stomach cancer	4.99e-05	0.000324	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Doxorubicin—stomach cancer	4.95e-05	0.000321	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Capecitabine—stomach cancer	4.94e-05	0.000321	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Epirubicin—stomach cancer	4.93e-05	0.00032	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Capecitabine—stomach cancer	4.92e-05	0.00032	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Capecitabine—stomach cancer	4.92e-05	0.00032	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Methotrexate—stomach cancer	4.92e-05	0.00032	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Doxorubicin—stomach cancer	4.91e-05	0.000319	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Doxorubicin—stomach cancer	4.91e-05	0.000319	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Epirubicin—stomach cancer	4.91e-05	0.000319	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Epirubicin—stomach cancer	4.88e-05	0.000317	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Doxorubicin—stomach cancer	4.84e-05	0.000315	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Methotrexate—stomach cancer	4.83e-05	0.000314	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Methotrexate—stomach cancer	4.83e-05	0.000314	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Methotrexate—stomach cancer	4.83e-05	0.000314	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Doxorubicin—stomach cancer	4.82e-05	0.000313	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Doxorubicin—stomach cancer	4.81e-05	0.000313	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	4.8e-05	0.000312	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Epirubicin—stomach cancer	4.79e-05	0.000311	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Methotrexate—stomach cancer	4.77e-05	0.00031	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Doxorubicin—stomach cancer	4.77e-05	0.00031	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Epirubicin—stomach cancer	4.77e-05	0.00031	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Epirubicin—stomach cancer	4.76e-05	0.00031	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Doxorubicin—stomach cancer	4.75e-05	0.000309	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Docetaxel—stomach cancer	4.73e-05	0.000308	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Doxorubicin—stomach cancer	4.72e-05	0.000307	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Epirubicin—stomach cancer	4.69e-05	0.000305	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Methotrexate—stomach cancer	4.67e-05	0.000304	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Epirubicin—stomach cancer	4.67e-05	0.000303	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Methotrexate—stomach cancer	4.63e-05	0.000301	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Docetaxel—stomach cancer	4.61e-05	0.0003	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Epirubicin—stomach cancer	4.6e-05	0.000299	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Methotrexate—stomach cancer	4.6e-05	0.000299	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Capecitabine—stomach cancer	4.58e-05	0.000298	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Doxorubicin—stomach cancer	4.56e-05	0.000296	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Docetaxel—stomach cancer	4.55e-05	0.000296	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Methotrexate—stomach cancer	4.54e-05	0.000295	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Doxorubicin—stomach cancer	4.54e-05	0.000295	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Methotrexate—stomach cancer	4.53e-05	0.000295	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Epirubicin—stomach cancer	4.52e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Epirubicin—stomach cancer	4.52e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Epirubicin—stomach cancer	4.52e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Doxorubicin—stomach cancer	4.52e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Epirubicin—stomach cancer	4.51e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Methotrexate—stomach cancer	4.5e-05	0.000292	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	4.49e-05	0.000292	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Methotrexate—stomach cancer	4.48e-05	0.000291	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Epirubicin—stomach cancer	4.47e-05	0.00029	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Capecitabine—stomach cancer	4.46e-05	0.00029	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Doxorubicin—stomach cancer	4.43e-05	0.000288	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Epirubicin—stomach cancer	4.42e-05	0.000287	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Doxorubicin—stomach cancer	4.41e-05	0.000287	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Methotrexate—stomach cancer	4.41e-05	0.000287	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Doxorubicin—stomach cancer	4.41e-05	0.000286	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Capecitabine—stomach cancer	4.4e-05	0.000286	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Docetaxel—stomach cancer	4.4e-05	0.000286	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Epirubicin—stomach cancer	4.37e-05	0.000284	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Doxorubicin—stomach cancer	4.34e-05	0.000282	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Epirubicin—stomach cancer	4.33e-05	0.000282	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Epirubicin—stomach cancer	4.33e-05	0.000282	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Methotrexate—stomach cancer	4.33e-05	0.000281	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Doxorubicin—stomach cancer	4.32e-05	0.000281	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Epirubicin—stomach cancer	4.31e-05	0.00028	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Epirubicin—stomach cancer	4.26e-05	0.000277	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Doxorubicin—stomach cancer	4.26e-05	0.000277	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Capecitabine—stomach cancer	4.26e-05	0.000277	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Epirubicin—stomach cancer	4.25e-05	0.000276	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Docetaxel—stomach cancer	4.25e-05	0.000276	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Epirubicin—stomach cancer	4.24e-05	0.000276	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Epirubicin—stomach cancer	4.23e-05	0.000275	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Methotrexate—stomach cancer	4.22e-05	0.000274	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Epirubicin—stomach cancer	4.21e-05	0.000274	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Epirubicin—stomach cancer	4.19e-05	0.000272	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Methotrexate—stomach cancer	4.19e-05	0.000272	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Doxorubicin—stomach cancer	4.18e-05	0.000272	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Doxorubicin—stomach cancer	4.18e-05	0.000272	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Doxorubicin—stomach cancer	4.18e-05	0.000272	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Doxorubicin—stomach cancer	4.17e-05	0.000271	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Methotrexate—stomach cancer	4.16e-05	0.00027	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	4.15e-05	0.00027	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Doxorubicin—stomach cancer	4.13e-05	0.000269	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Epirubicin—stomach cancer	4.13e-05	0.000269	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Methotrexate—stomach cancer	4.13e-05	0.000268	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Methotrexate—stomach cancer	4.12e-05	0.000268	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Capecitabine—stomach cancer	4.11e-05	0.000267	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Doxorubicin—stomach cancer	4.09e-05	0.000266	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Docetaxel—stomach cancer	4.09e-05	0.000266	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Methotrexate—stomach cancer	4.08e-05	0.000265	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Docetaxel—stomach cancer	4.05e-05	0.000263	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Epirubicin—stomach cancer	4.05e-05	0.000263	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Docetaxel—stomach cancer	4.05e-05	0.000263	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Doxorubicin—stomach cancer	4.04e-05	0.000263	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Methotrexate—stomach cancer	4.03e-05	0.000262	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Docetaxel—stomach cancer	4.03e-05	0.000262	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Doxorubicin—stomach cancer	4.01e-05	0.000261	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Doxorubicin—stomach cancer	4.01e-05	0.000261	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Methotrexate—stomach cancer	4e-05	0.00026	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Methotrexate—stomach cancer	3.99e-05	0.00026	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Doxorubicin—stomach cancer	3.98e-05	0.000259	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Capecitabine—stomach cancer	3.96e-05	0.000257	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Epirubicin—stomach cancer	3.95e-05	0.000257	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Doxorubicin—stomach cancer	3.95e-05	0.000256	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Doxorubicin—stomach cancer	3.93e-05	0.000256	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Doxorubicin—stomach cancer	3.93e-05	0.000255	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Capecitabine—stomach cancer	3.92e-05	0.000255	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Epirubicin—stomach cancer	3.92e-05	0.000255	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Capecitabine—stomach cancer	3.92e-05	0.000255	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Doxorubicin—stomach cancer	3.91e-05	0.000254	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Capecitabine—stomach cancer	3.9e-05	0.000253	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Doxorubicin—stomach cancer	3.9e-05	0.000253	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Epirubicin—stomach cancer	3.89e-05	0.000253	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Doxorubicin—stomach cancer	3.88e-05	0.000252	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Epirubicin—stomach cancer	3.86e-05	0.000251	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Epirubicin—stomach cancer	3.85e-05	0.00025	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Doxorubicin—stomach cancer	3.82e-05	0.000248	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Docetaxel—stomach cancer	3.82e-05	0.000248	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Methotrexate—stomach cancer	3.82e-05	0.000248	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Epirubicin—stomach cancer	3.82e-05	0.000248	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Methotrexate—stomach cancer	3.79e-05	0.000246	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Epirubicin—stomach cancer	3.77e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Doxorubicin—stomach cancer	3.75e-05	0.000244	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Epirubicin—stomach cancer	3.74e-05	0.000243	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Epirubicin—stomach cancer	3.74e-05	0.000243	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Epirubicin—stomach cancer	3.71e-05	0.000241	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Capecitabine—stomach cancer	3.7e-05	0.00024	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Methotrexate—stomach cancer	3.68e-05	0.000239	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Methotrexate—stomach cancer	3.66e-05	0.000238	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Methotrexate—stomach cancer	3.66e-05	0.000238	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Doxorubicin—stomach cancer	3.65e-05	0.000238	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Doxorubicin—stomach cancer	3.63e-05	0.000236	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Doxorubicin—stomach cancer	3.6e-05	0.000234	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Doxorubicin—stomach cancer	3.58e-05	0.000232	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Epirubicin—stomach cancer	3.57e-05	0.000232	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Doxorubicin—stomach cancer	3.57e-05	0.000232	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Epirubicin—stomach cancer	3.54e-05	0.00023	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Doxorubicin—stomach cancer	3.53e-05	0.000229	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Doxorubicin—stomach cancer	3.49e-05	0.000227	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Doxorubicin—stomach cancer	3.46e-05	0.000225	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Doxorubicin—stomach cancer	3.46e-05	0.000225	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Epirubicin—stomach cancer	3.44e-05	0.000224	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Doxorubicin—stomach cancer	3.43e-05	0.000223	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Epirubicin—stomach cancer	3.43e-05	0.000223	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Epirubicin—stomach cancer	3.43e-05	0.000223	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Methotrexate—stomach cancer	3.41e-05	0.000222	CcSEcCtD
Medroxyprogesterone Acetate—Testosterone—ALB—stomach cancer	3.34e-05	0.0517	CrCbGaD
Medroxyprogesterone Acetate—Asthenia—Methotrexate—stomach cancer	3.32e-05	0.000216	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Doxorubicin—stomach cancer	3.3e-05	0.000215	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Doxorubicin—stomach cancer	3.28e-05	0.000213	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Methotrexate—stomach cancer	3.28e-05	0.000213	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Epirubicin—stomach cancer	3.19e-05	0.000208	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Doxorubicin—stomach cancer	3.19e-05	0.000207	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Doxorubicin—stomach cancer	3.17e-05	0.000206	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Doxorubicin—stomach cancer	3.17e-05	0.000206	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Methotrexate—stomach cancer	3.17e-05	0.000206	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Epirubicin—stomach cancer	3.11e-05	0.000202	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Epirubicin—stomach cancer	3.07e-05	0.000199	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Methotrexate—stomach cancer	3.06e-05	0.000199	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Epirubicin—stomach cancer	2.97e-05	0.000193	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Doxorubicin—stomach cancer	2.95e-05	0.000192	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Methotrexate—stomach cancer	2.94e-05	0.000191	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Methotrexate—stomach cancer	2.92e-05	0.00019	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Methotrexate—stomach cancer	2.92e-05	0.00019	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Methotrexate—stomach cancer	2.9e-05	0.000189	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Doxorubicin—stomach cancer	2.88e-05	0.000187	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Epirubicin—stomach cancer	2.87e-05	0.000186	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Doxorubicin—stomach cancer	2.84e-05	0.000184	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Epirubicin—stomach cancer	2.76e-05	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Methotrexate—stomach cancer	2.75e-05	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Doxorubicin—stomach cancer	2.74e-05	0.000178	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Epirubicin—stomach cancer	2.73e-05	0.000178	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Epirubicin—stomach cancer	2.73e-05	0.000177	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Epirubicin—stomach cancer	2.72e-05	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Doxorubicin—stomach cancer	2.65e-05	0.000172	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Epirubicin—stomach cancer	2.57e-05	0.000167	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Doxorubicin—stomach cancer	2.55e-05	0.000166	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Doxorubicin—stomach cancer	2.53e-05	0.000164	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Doxorubicin—stomach cancer	2.53e-05	0.000164	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Doxorubicin—stomach cancer	2.51e-05	0.000163	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Doxorubicin—stomach cancer	2.38e-05	0.000155	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6ST—stomach cancer	1.11e-05	0.000132	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FYN—stomach cancer	1.11e-05	0.000132	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ALB—stomach cancer	1.11e-05	0.000132	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NT5E—stomach cancer	1.1e-05	0.000131	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PGAM1—stomach cancer	1.1e-05	0.000131	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CDKN1B—stomach cancer	1.09e-05	0.00013	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TYMP—stomach cancer	1.08e-05	0.000129	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—FADS1—stomach cancer	1.08e-05	0.000129	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.07e-05	0.000128	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.07e-05	0.000128	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—APC—stomach cancer	1.07e-05	0.000127	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—NOS3—stomach cancer	1.06e-05	0.000126	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—SMAD4—stomach cancer	1.05e-05	0.000125	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PLCE1—stomach cancer	1.05e-05	0.000125	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALDH7A1—stomach cancer	1.05e-05	0.000125	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FGFR2—stomach cancer	1.04e-05	0.000124	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—SMAD4—stomach cancer	1.04e-05	0.000123	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AGTR2—stomach cancer	1.03e-05	0.000123	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HSPB1—stomach cancer	1.03e-05	0.000123	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—F2R—stomach cancer	1.02e-05	0.000121	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—BMP2—stomach cancer	1.02e-05	0.000121	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SREBF2—stomach cancer	1.01e-05	0.00012	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CDKN1A—stomach cancer	1.01e-05	0.00012	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—UMPS—stomach cancer	1.01e-05	0.00012	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AKR1C3—stomach cancer	1e-05	0.000119	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—RORA—stomach cancer	9.99e-06	0.000119	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR1A—stomach cancer	9.92e-06	0.000118	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6R—stomach cancer	9.89e-06	0.000118	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTGS2—stomach cancer	9.67e-06	0.000115	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—ERCC2—stomach cancer	9.6e-06	0.000114	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ANXA1—stomach cancer	9.58e-06	0.000114	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PGLS—stomach cancer	9.57e-06	0.000114	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—BLVRB—stomach cancer	9.57e-06	0.000114	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IRS2—stomach cancer	9.51e-06	0.000113	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—PPARG—stomach cancer	9.5e-06	0.000113	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—ERCC2—stomach cancer	9.46e-06	0.000113	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ALDOB—stomach cancer	9.36e-06	0.000111	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ECHS1—stomach cancer	9.35e-06	0.000111	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PDHA1—stomach cancer	9.35e-06	0.000111	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ADRB1—stomach cancer	9.28e-06	0.00011	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SERPINE1—stomach cancer	9.26e-06	0.00011	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CAV1—stomach cancer	9.23e-06	0.00011	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—APOA1—stomach cancer	9.2e-06	0.00011	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPAP2A—stomach cancer	9.13e-06	0.000109	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—STAT3—stomach cancer	9.01e-06	0.000107	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RHOA—stomach cancer	8.94e-06	0.000106	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RPS6—stomach cancer	8.87e-06	0.000106	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NOS3—stomach cancer	8.84e-06	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	8.83e-06	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	8.81e-06	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TYMP—stomach cancer	8.79e-06	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—FADS1—stomach cancer	8.79e-06	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PRKCB—stomach cancer	8.78e-06	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6ST—stomach cancer	8.75e-06	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ALOX5—stomach cancer	8.71e-06	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—MYC—stomach cancer	8.67e-06	0.000103	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MAPK3—stomach cancer	8.61e-06	0.000102	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—DPYD—stomach cancer	8.56e-06	0.000102	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—SERPINE1—stomach cancer	8.56e-06	0.000102	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—MYC—stomach cancer	8.54e-06	0.000102	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—APC—stomach cancer	8.4e-06	0.0001	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MYC—stomach cancer	8.37e-06	9.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ERBB2—stomach cancer	8.27e-06	9.85e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SREBF2—stomach cancer	8.23e-06	9.8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MAPK1—stomach cancer	8.19e-06	9.75e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—EGFR—stomach cancer	8.19e-06	9.75e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HBEGF—stomach cancer	8.15e-06	9.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CKB—stomach cancer	8.14e-06	9.69e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—FBP1—stomach cancer	8.14e-06	9.69e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CA1—stomach cancer	8.14e-06	9.69e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NDUFA2—stomach cancer	8.14e-06	9.69e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—RORA—stomach cancer	8.13e-06	9.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CXCL8—stomach cancer	7.84e-06	9.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6R—stomach cancer	7.8e-06	9.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.76e-06	9.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—KRAS—stomach cancer	7.73e-06	9.21e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CDKN1B—stomach cancer	7.66e-06	9.12e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PLIN2—stomach cancer	7.65e-06	9.11e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALDOB—stomach cancer	7.62e-06	9.07e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTT1—stomach cancer	7.57e-06	9.02e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ADRB2—stomach cancer	7.52e-06	8.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP2A6—stomach cancer	7.49e-06	8.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CA2—stomach cancer	7.44e-06	8.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PPP2R1A—stomach cancer	7.37e-06	8.77e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PPARG—stomach cancer	7.32e-06	8.72e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—MAPK3—stomach cancer	7.31e-06	8.71e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCND1—stomach cancer	7.31e-06	8.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SERPINE1—stomach cancer	7.31e-06	8.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—JUN—stomach cancer	7.29e-06	8.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AKR1C3—stomach cancer	7.28e-06	8.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NT5E—stomach cancer	7.25e-06	8.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PGAM1—stomach cancer	7.25e-06	8.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PPARG—stomach cancer	7.21e-06	8.58e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	7.19e-06	8.56e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	7.17e-06	8.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—MYC—stomach cancer	7.11e-06	8.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PIK3CA—stomach cancer	7.11e-06	8.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ENO1—stomach cancer	7.1e-06	8.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MMP9—stomach cancer	7.09e-06	8.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALOX5—stomach cancer	7.09e-06	8.44e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CDKN1A—stomach cancer	7.07e-06	8.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RHOA—stomach cancer	7.05e-06	8.39e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.98e-06	8.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NOS3—stomach cancer	6.98e-06	8.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—DPYD—stomach cancer	6.97e-06	8.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALDH7A1—stomach cancer	6.92e-06	8.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PLCE1—stomach cancer	6.92e-06	8.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MAPK8—stomach cancer	6.9e-06	8.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SMAD4—stomach cancer	6.84e-06	8.15e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—UMPS—stomach cancer	6.63e-06	7.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—SERPINE1—stomach cancer	6.6e-06	7.85e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HRAS—stomach cancer	6.57e-06	7.83e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ERBB2—stomach cancer	6.52e-06	7.77e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FYN—stomach cancer	6.5e-06	7.73e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—SERPINE1—stomach cancer	6.5e-06	7.73e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VEGFA—stomach cancer	6.37e-06	7.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	6.32e-06	7.52e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—STAT3—stomach cancer	6.31e-06	7.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CD44—stomach cancer	6.29e-06	7.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IL6—stomach cancer	6.29e-06	7.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CXCL8—stomach cancer	6.19e-06	7.37e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PDHA1—stomach cancer	6.17e-06	7.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ECHS1—stomach cancer	6.17e-06	7.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTT1—stomach cancer	6.16e-06	7.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.11e-06	7.27e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FGFR2—stomach cancer	6.1e-06	7.26e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP2A6—stomach cancer	6.09e-06	7.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CDKN1B—stomach cancer	6.04e-06	7.19e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MAPK3—stomach cancer	6.03e-06	7.18e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PIK3CA—stomach cancer	5.95e-06	7.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AKR1C3—stomach cancer	5.93e-06	7.06e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MYC—stomach cancer	5.86e-06	6.98e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TYMP—stomach cancer	5.8e-06	6.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—FADS1—stomach cancer	5.8e-06	6.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ENO1—stomach cancer	5.78e-06	6.88e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCND1—stomach cancer	5.76e-06	6.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—JUN—stomach cancer	5.75e-06	6.85e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MAPK1—stomach cancer	5.73e-06	6.83e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EGFR—stomach cancer	5.73e-06	6.83e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.68e-06	6.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MMP9—stomach cancer	5.6e-06	6.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IRS2—stomach cancer	5.58e-06	6.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CDKN1A—stomach cancer	5.58e-06	6.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—MAPK3—stomach cancer	5.57e-06	6.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MAPK8—stomach cancer	5.44e-06	6.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SREBF2—stomach cancer	5.43e-06	6.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—MYC—stomach cancer	5.42e-06	6.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—KRAS—stomach cancer	5.42e-06	6.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CAV1—stomach cancer	5.41e-06	6.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOA1—stomach cancer	5.4e-06	6.43e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—RORA—stomach cancer	5.36e-06	6.39e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPP2R1A—stomach cancer	5.35e-06	6.37e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTP1—stomach cancer	5.25e-06	6.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—HMOX1—stomach cancer	5.18e-06	6.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PRKCB—stomach cancer	5.15e-06	6.14e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6ST—stomach cancer	5.13e-06	6.11e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CD44—stomach cancer	5.12e-06	6.1e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALDOB—stomach cancer	5.03e-06	5.98e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VEGFA—stomach cancer	5.03e-06	5.98e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—STAT3—stomach cancer	4.98e-06	5.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PIK3CA—stomach cancer	4.98e-06	5.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.97e-06	5.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APC—stomach cancer	4.93e-06	5.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TYMS—stomach cancer	4.88e-06	5.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTM1—stomach cancer	4.82e-06	5.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TP53—stomach cancer	4.81e-06	5.73e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MAPK3—stomach cancer	4.75e-06	5.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALOX5—stomach cancer	4.67e-06	5.56e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MYC—stomach cancer	4.62e-06	5.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HRAS—stomach cancer	4.6e-06	5.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—DPYD—stomach cancer	4.6e-06	5.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6R—stomach cancer	4.58e-06	5.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ERCC2—stomach cancer	4.54e-06	5.4e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MAPK1—stomach cancer	4.52e-06	5.39e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EGFR—stomach cancer	4.52e-06	5.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6—stomach cancer	4.41e-06	5.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPP2R1A—stomach cancer	4.36e-06	5.19e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MAPK3—stomach cancer	4.29e-06	5.11e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SERPINE1—stomach cancer	4.29e-06	5.11e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—KRAS—stomach cancer	4.27e-06	5.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTP1—stomach cancer	4.27e-06	5.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MTHFR—stomach cancer	4.26e-06	5.08e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MAPK3—stomach cancer	4.23e-06	5.03e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—HMOX1—stomach cancer	4.21e-06	5.02e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MYC—stomach cancer	4.17e-06	4.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RHOA—stomach cancer	4.14e-06	4.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MYC—stomach cancer	4.11e-06	4.89e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOS3—stomach cancer	4.09e-06	4.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTT1—stomach cancer	4.07e-06	4.84e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP2A6—stomach cancer	4.02e-06	4.78e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TYMS—stomach cancer	3.97e-06	4.73e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CAV1—stomach cancer	3.93e-06	4.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTM1—stomach cancer	3.93e-06	4.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PIK3CA—stomach cancer	3.93e-06	4.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOA1—stomach cancer	3.92e-06	4.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AKR1C3—stomach cancer	3.91e-06	4.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ERBB2—stomach cancer	3.83e-06	4.56e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ENO1—stomach cancer	3.81e-06	4.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TP53—stomach cancer	3.8e-06	4.52e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.76e-06	4.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ERCC2—stomach cancer	3.69e-06	4.4e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HRAS—stomach cancer	3.63e-06	4.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCL8—stomach cancer	3.63e-06	4.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CDKN1B—stomach cancer	3.55e-06	4.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6—stomach cancer	3.48e-06	4.14e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MTHFR—stomach cancer	3.47e-06	4.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPARG—stomach cancer	3.46e-06	4.12e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCND1—stomach cancer	3.38e-06	4.03e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CD44—stomach cancer	3.38e-06	4.02e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—JUN—stomach cancer	3.38e-06	4.02e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP9—stomach cancer	3.28e-06	3.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CDKN1A—stomach cancer	3.27e-06	3.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CAV1—stomach cancer	3.2e-06	3.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAPK8—stomach cancer	3.19e-06	3.8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOA1—stomach cancer	3.19e-06	3.8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ALB—stomach cancer	3.11e-06	3.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.06e-06	3.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NOS3—stomach cancer	2.97e-06	3.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VEGFA—stomach cancer	2.95e-06	3.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—STAT3—stomach cancer	2.92e-06	3.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.87e-06	3.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTP1—stomach cancer	2.82e-06	3.35e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPARG—stomach cancer	2.81e-06	3.35e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAPK3—stomach cancer	2.79e-06	3.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HMOX1—stomach cancer	2.78e-06	3.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—stomach cancer	2.72e-06	3.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MYC—stomach cancer	2.71e-06	3.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAPK1—stomach cancer	2.65e-06	3.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EGFR—stomach cancer	2.65e-06	3.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TYMS—stomach cancer	2.62e-06	3.12e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTM1—stomach cancer	2.59e-06	3.08e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALB—stomach cancer	2.53e-06	3.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KRAS—stomach cancer	2.51e-06	2.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ERCC2—stomach cancer	2.43e-06	2.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NOS3—stomach cancer	2.42e-06	2.88e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PIK3CA—stomach cancer	2.3e-06	2.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MTHFR—stomach cancer	2.29e-06	2.72e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TP53—stomach cancer	2.23e-06	2.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—stomach cancer	2.21e-06	2.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HRAS—stomach cancer	2.13e-06	2.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CAV1—stomach cancer	2.11e-06	2.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOA1—stomach cancer	2.11e-06	2.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6—stomach cancer	2.04e-06	2.43e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPARG—stomach cancer	1.86e-06	2.21e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PIK3CA—stomach cancer	1.67e-06	1.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALB—stomach cancer	1.67e-06	1.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NOS3—stomach cancer	1.6e-06	1.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—stomach cancer	1.46e-06	1.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.36e-06	1.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3CA—stomach cancer	8.98e-07	1.07e-05	CbGpPWpGaD
